Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Strydom

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|November 13, 2021
COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society SurveyDavid Emes, Anke Hüls, Nicole Baumer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2020
Further understanding the connection between Alzheimer's disease and Down syndromeHeather M Snyder, Lisa J Bain, Adam M Brickman, et al.
The Lancet. Neurology|July 24, 2021
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort studyMaria Carmona-Iragui, Daniel Alcolea, Isabel Barroeta, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 1, 2018
Delineating the psychiatric and behavioral phenotype of recurrent 2q13 deletions and duplicationsKate Wolfe, Andrew McQuillin, Viola Alesi, et al.
Vaccines|April 23, 2022
COVID-19 Vaccination of Individuals with Down Syndrome-Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be VaccinatedAnke Hüls, Patrick T Feany, Sophia Isabella Zisman, et al.
Neuromolecular Medicine|January 5, 2025
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research SocietyLisi Flores-Aguilar, Eric D Hamlett, Paula Araya, et al.
Molecular Psychiatry|July 17, 2021
Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Molecular Psychiatry|July 11, 2020
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Nature Communications|June 8, 2021
A multicentre validation study of the diagnostic value of plasma neurofilament lightNicholas J Ashton, Shorena Janelidze, Ahmad Al Khleifat, et al.
Ebiomedicine|July 14, 2023
Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsAoife Murray, Gillian Gough, Ana Cindrić, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|November 13, 2021
COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society SurveyDavid Emes, Anke Hüls, Nicole Baumer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 17, 2020
Further understanding the connection between Alzheimer's disease and Down syndromeHeather M Snyder, Lisa J Bain, Adam M Brickman, et al.
The Lancet. Neurology|July 24, 2021
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort studyMaria Carmona-Iragui, Daniel Alcolea, Isabel Barroeta, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 1, 2018
Delineating the psychiatric and behavioral phenotype of recurrent 2q13 deletions and duplicationsKate Wolfe, Andrew McQuillin, Viola Alesi, et al.
Vaccines|April 23, 2022
COVID-19 Vaccination of Individuals with Down Syndrome-Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be VaccinatedAnke Hüls, Patrick T Feany, Sophia Isabella Zisman, et al.
Neuromolecular Medicine|January 5, 2025
Imagine, Discover, Inspire: Proceedings of the 4th International Conference of the Trisomy 21 Research SocietyLisi Flores-Aguilar, Eric D Hamlett, Paula Araya, et al.
Molecular Psychiatry|July 17, 2021
Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Molecular Psychiatry|July 11, 2020
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Nature Communications|June 8, 2021
A multicentre validation study of the diagnostic value of plasma neurofilament lightNicholas J Ashton, Shorena Janelidze, Ahmad Al Khleifat, et al.
Ebiomedicine|July 14, 2023
Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsAoife Murray, Gillian Gough, Ana Cindrić, et al.
Pageof 12